033270 — Korea United Pharm Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual cashflow statement for Korea United Pharm, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	26,613	28,649	45,275	48,262	32,453
Depreciation
Amortisation
Non-Cash Items	12,537	7,874	14,789	8,472	2,486
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-10,440	174	-5,271	-17,059	-19,415
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	36,962	44,085	63,782	49,770	26,794
Capital Expenditures	-12,546	-12,789	-24,207	-31,309	-21,222
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-21,181	-4,909	-63,695	-24,222	32,923
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-33,727	-17,698	-87,902	-55,531	11,701
Financing Cash Flow Items	-30.5	-73.5	560	375	270
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-1,782	-8,197	-10,586	2,546	-29,458
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	477	20,348	-33,933	-2,982	9,789